|
Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test
RECRUITINGN/ASponsored by Grand Hôpital de Charleroi
Actively Recruiting
PhaseN/A
SponsorGrand Hôpital de Charleroi
Started2026-09-15
Est. completion2028-12-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07868640
Summary
The pathological anatomy laboratory, which is managed by the IPG, would involve monitoring patients being treated for cancer and receiving care at the GHDC in order to take blood samples from those in whom the presence of plasma ctDNA carrying a mutation in a specific gene is suspected - a mutation detectable by the TST79 test.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients with the following types of cancer may be invited to donate blood as part of one of two approaches: * lung adenocarcinoma * colorectal adenocarcinoma * breast carcinoma * prostate adenocarcinoma * clear cell renal cell carcinoma * GIST/gastrointestinal stromal tumour * melanoma * urothelial carcinoma * endometrial carcinoma * high-grade ovarian carcinoma
Conditions1
Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorGrand Hôpital de Charleroi
Started2026-09-15
Est. completion2028-12-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07868640